Yamazaki smiled bitterly and found that it seemed that he had never taken advantage of the competition between himself and An Tianmin's company and Liang Sanping. Of course, he didn't seem to have suffered much after the contract was finalized.

Thinking of this, Yamazaki couldn't help but smile bitterly. Now Xia Zhendong and others have obviously learned a lot of tricks from Liang Sanping, and the points of negotiation are pinched on the main points of Wanhong, but they also leave you profits. It's not for you to refuse, but you feel at a loss if you agree.

"First of all, we will conduct a joint test after the success of the farming practice. Especially when it comes to the effect of drug treatment, we can both dismiss specialists. It is even possible to conduct clinical trials in Japan......"

Yamazaki kept recording the various collaborations proposed by Xia Zhendong and others, and nodded frequently. In the final analysis, the medicines and supplements that Liang Sanping and his people researched based on the ancient prescriptions of traditional Chinese medicine had to be sold to the Japanese market through a Japanese company.

And if they want to sell to Europe and the United States, then Japan will definitely have an advantage over Liang Sanping and themselves. At the very least, I have a lot of experience in applying for FDA in Japan.

This is completely different from Liang Sanping. And there is a reason why Liang Sanping is now in a hurry to make traditional Chinese medicine. Because he knows that in the future, traditional Chinese medicine, which was once criticized by the Chinese people, will have a huge market abroad.

In China, traditional Chinese medicine has always been criticized. At one time, some people even denounced Chinese medicine as a so-called "pseudoscience". Some people add fuel to the fire, and it seems that they will not stop at the end of traditional Chinese medicine or make their prescriptions public.

Some of these people are pretending to understand. And more of them are pretending to be confused. The reason is very simple, because as of 2009, there have been more than 300,000 secret clinical formulas in China, more than 60,000 of which have been recorded, and 35 categories of Chinese patent medicines. With 43 dosage forms, the secret recipe of traditional Chinese medicine has become an important source of new drug development.

At the same time, countries such as Japan and South Korea are working hard to carry out the research and development of traditional Chinese medicine, they buy raw materials from China at a low price, refine them, and then sell them to all parts of the world at a price dozens or even hundreds of times higher than that of domestic traditional Chinese medicine.

For example, the "Heart-Saving Pill" produced in Japan. It is developed on the basis of China's "Liushen Pill", with annual sales of hundreds of millions of dollars; South Korea's "Bezoar Qingxin Liquid" originates from China's "Bezoar Qingxin Pill", with an annual output value of nearly 100 million US dollars.

As of 2009, more than 900 kinds of traditional Chinese medicines, which have been criticized by many Chinese people, have been patented by foreign companies.

Since April 1992, Koreans have successively applied to the patent offices of many countries in the world, including South Korea, China, Japan and the United States, for invention patents such as Niu Huang Qingxin Liquid, Niu Huang Qingxin Micro Capsule and Niu Huang Qingxin Pill New Prescription Composition, and have seized the domestic and foreign markets of Tong Ren Tang with new dosage forms and new process patents. Among them, the annual output value of the variety of bezoar Qingxin liquid alone reaches 70 million US dollars!

Not only that, Korean traditional Chinese medicine directly changed the name of "traditional Chinese medicine" to Korean medicine in 1980. Compared to Japan, there are fewer varieties of traditional Chinese medicine in Korea, about 100 varieties, but in the development of traditional Chinese medicine, Korea is more specialized than Japan.

The most typical is Korean ginseng, which is a specialty of Korea. According to statistics, Korean products are 28 times more expensive than Chinese ginseng exports of the same grade! This qiē made Liang Sanping extremely distressed and helpless.

What is more noteworthy is that in 2008, the export value of proprietary Chinese medicines showed a deficit for the first time in 13 years, which means that there are fewer exports and more imports. We export the most low-profit Chinese herbal medicines, while Japanese and Korean companies import our Chinese herbal medicines for deep processing, and finally make high-profit Chinese patent medicines for re-export.

Ridiculously. As the country of origin of traditional Chinese medicine, it has been questioned and criticized. So much so that China was eventually reduced to a supplier of raw materials for traditional Chinese medicine, while Japan and South Korea made huge profits abroad with a smile on these traditional Chinese medicines that were abandoned by the Chinese people.

And some media are constantly attacking "formula protection". Trying to get many of the protected ancient recipes to publish their own prescriptions. And once these prescriptions are announced as they wish, all they get is to let Japan and South Korea take advantage.

Our export ability is not as good as others, and our experience in obtaining sales qualifications is not as good as others. In the end, our patents were preemptively registered by these Japanese and Korean companies abroad, and then we made a lot of money with the capital left by our ancestors.

These people may be pretending to understand. But perhaps...... More people are pretending to be confused. There is even some people who have accepted certain benefits. Only then did they stand up and instigate and provoke the occurrence of this kind of thing.

"Our TCM must occupy a place in the international market! Not only Japan, South Korea, but also Europe and the United States, where we have a huge consumer market! ”

But Liang Sanping smiled and said to Zhou Jie and others: "In the theory of traditional Chinese medicine, there is a 'medical treatment before the disease.'" Traditional Chinese medicine treats desire diseases. The statement that we have been cured of the disease' fully illustrates the importance we attach to our daily health conditioning......"

"That's what we're focusing on right now. We need to make certain 'dietary supplements', which we call therapeutic supplements......"

If you try to get Chinese medicine into the United States directly, this is undoubtedly extremely difficult. The simplest financial problem can make Liang Sanping have a headache. To successfully register a new drug in the United States, it is necessary to go through multiple stages of clinical research application, phase I clinical trial, phase II clinical trial, phase III clinical trial, and new drug registration application.

The above five items need to spend an average of no less than 8 years and hundreds of millions of dollars, and if you want to count the failures in the middle, the average pre-marketing cost of a new drug may reach 800 million US dollars!

800 million US dollars, Liang Sanping will not get so much money unless he robs the treasury? ! And as a dietary supplement, it's the best way to test the waters first. It's also the easiest way.

In fact, this is also a decision made by Liang Sanping after thinking about it for a long time. Now An Tianmin is still too poor, and it is difficult for Liang Sanping to do something. If traditional Chinese medicine directly tries to enter the U.S. market, it will definitely cause resistance and embarrassment among traditional Chinese medicine companies, including Japan and South Korea. Even the U.S. pharmaceutical industry will come looking for trouble.

Such an example is not unprecedented, and under the strong publicity offensive of the former Xuezhikang capsule, Cholestin has entered 35,000 supermarkets in the United States, including Wal-Mart.

Mainstream sales channels, coupled with prices that are several hundred dollars cheaper than Western medicines, have led to an increase in the export trade volume of special red yeast rice, which costs tens of thousands of dollars per ton, year after year, and hundreds of tons were sold in 1999.

Just as Americans were immersed in the fact that they could get the same satisfactory results as Western drugs for a small amount of money, some Western drug manufacturers began to make "small reports" to the FDA, saying that Cholestin was not a health supplement, but a drug.

As a result, the FDA went to court with the American health product company, and although the company won the first and second trials, the 2001 U.S. Supreme Court decision finally stopped Cholestin's sales in the United States.

At present, there is no clear definition of botanical medicine in the United States, so many traditional Chinese medicines that are all plant ingredients are sold in the name of "dietary supplements" in later generations.

It's not impossible for Chinese medicine to be sold as food supplements, but if your sales affect Western medicine, then the consequences are ...... Like Cholestin's big selling, let the Western drug manufacturers be sued when their own interests are damaged.

Liang Sanping doesn't want to touch this brow, but the concept of "treating the disease before the disease" in traditional Chinese medicine can be played at this time. It is okay to enter the U.S. market on the grounds of nutrition and dietary supplements.

Moreover, this will not affect the original interests of Japan, South Korea and other countries in Europe and the United States. When the time is sufficient and the US FDA has figured out the way, Liang Sanping will launch an action to push traditional Chinese medicine into the US market.

"What we need now is a stepping stone. If this stepping stone is done, then we will be able to open the European and American markets smoothly. and even expand our country's influence in Europe and the United States, and promote traditional medicine. ”

Liang Sanping looked at Zhou Jie and the others solemnly, and said: "In 1980, the Koreans actually changed the name of traditional Chinese medicine passed down by us to 'Korean medicine'!" This incident makes me feel extremely distressed......"

"The treasure that has been passed down by our ancestors for thousands of years has become someone else's when it comes to us. If we don't catch up, we don't protect these treasures handed down by our ancestors. Maybe not many years later, people in the world will only know 'Korean medicine' and 'Korean medicine', but they no longer know that their original name is 'Chinese medicine'......"

Liang Sanping's words made Zhou Jie and others angry and rushed to the crown. At this time, the country was still isolated from the outside world, and they didn't know much about the situation outside, and they didn't even know that traditional Chinese medicine was already called "Korean medicine" in Korea.

"These dead Goryeo sticks! It's shameless! It's so shameless!! Zhou Jie suddenly stood up and roared angrily, and the faces of several other Chinese medicine researchers were extremely ugly.

Several of them are skills that have been passed down from generation to generation by their ancestors, and if they really let Koreans do it. Then to put it mildly, they died and didn't have the face to see their ancestors.

"Sanping! Rest assured, we will do our best in this matter! We can't let those sticks take advantage of us! But he saw Zhou Jie say viciously: "When it comes to traditional Chinese medicine, we are their ancestors!" The little bit of ability of the Japanese, that is, to develop from "Treatise on Typhoid Fever", our recipes are much stronger than them! ”

Liang Sanping nodded solemnly, he specially held this meeting with Zhou Jie and them. It is to tell them the current status quo of traditional Chinese medicine, if it is not protected and developed. Then what awaits Chinese medicine is likely to be gradually extinct......

And in the end, China, as the birthplace of traditional Chinese medicine. But it can only miserably become a source of traditional Chinese medicine for others...... (To be continued......)